Results 71 to 80 of about 19,736,678 (402)

Renewing the fight to end tuberculosis

open access: yesThe Lancet Public Health, 2021
The Lancet Public Health
doaj   +1 more source

The future of public health practice in Europe [PDF]

open access: yes, 2016
The European Public Health Association (EUPHA) identifies research, training, policy and practice as the four pillars for all its work. At a conference organised by the Association of School of Public Health in the European Region (ASPHER) in May 2016,
Azzopardi Muscat, Natasha
core   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Health and inequity in Australia

open access: yesThe Lancet Public Health, 2023
The Lancet Public Health
doaj   +1 more source

Advancing the Right to Health: The Vital Role of Law [PDF]

open access: yes, 2017
Effective laws and an enabling legal environment are essential to a healthy society. Most public health challenges – from infectious and non-communicable diseases to injuries, from mental illness to universal health coverage – have a legal component.
Cabrera, Oscar A.   +4 more
core   +1 more source

Global Public Health Burden of Heart Failure.

open access: yesCardiac failure review, 2016
Heart failure (HF) is a global pandemic affecting at least 26 million people worldwide and is increasing in prevalence. HF health expenditures are considerable and will increase dramatically with an ageing population.
G. Savarese, L. Lund
semanticscholar   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

COVID-19 in France: challenges and opportunities

open access: yesThe Lancet Public Health, 2021
The Lancet Public Health
doaj   +1 more source

Home - About - Disclaimer - Privacy